{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T22:49:15Z","timestamp":1774392555553,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bestpracticeobgyn.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.bpobgyn.2015.03.006","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T23:52:42Z","timestamp":1428277962000},"page":"858-869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Ovarian, fallopian tube and peritoneal cancer staging: Rationale and explanation of new FIGO staging 2013"],"prefix":"10.1016","volume":"29","author":[{"given":"Jaime","family":"Prat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2015.03.006_bib1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib2","series-title":"De Vita, Hellman, and Rosenberg's Cancer: principles and practice of oncology","first-page":"1368","article-title":"Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma","author":"Cannistra","year":"2011"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib3","series-title":"WHO classification of tumours of female reproductive organs","year":"2014"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib4","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.humpath.2009.04.017","article-title":"Ovarian carcinoma pathology and genetics: recent advances","volume":"40","author":"Gilks","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00428-012-1203-5","article-title":"Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features","volume":"460","author":"Prat","year":"2012","journal-title":"Virchows Arch"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib6","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib7","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib9","first-page":"296A","article-title":"Does BRCA+ pelvic serous cancer have a dual pathogenesis? the paradox of tubal intraepithelial carcinoma (TIC), early and advanced disease","volume":"27","author":"Meserve","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib10","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/path.4263","article-title":"Through the glass darkly: intraepithelial neoplasia, top-down differentiation, and the road to ovarian cancer","volume":"231","author":"Crum","year":"2013","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib11","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jnci\/95.6.484","article-title":"Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma","volume":"95","author":"Singer","year":"2003","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.pas.0000146025.91953.8d","article-title":"Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation","volume":"29","author":"Singer","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib13","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrc3144","article-title":"Rethinking ovarian cancer: recommendations for improving outcomes","volume":"11","author":"Vaughan","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int J Gynecol Obstet"},{"issue":"Suppl. 1","key":"10.1016\/j.bpobgyn.2015.03.006_bib15","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/S0020-7292(06)60033-7","article-title":"Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Heintz","year":"2006","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1525-1438.2007.01058.x","article-title":"Pathology of stage I versus stage III ovarian carcinoma with implications for pathogenesis and screening","volume":"18","author":"Yemelyanova","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PGP.0b013e3181af2372","article-title":"Prognostic factors for stage I ovarian carcinoma","volume":"29","author":"Seidman","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib18","first-page":"263","article-title":"Prognostic factors in patients with stage I epithelial ovarian cancer","volume":"75","author":"Dembo","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib19","series-title":"Principles and practice of gynecologic oncology","first-page":"895","article-title":"Epithelial ovarian cancer","author":"Ozols","year":"2005"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ygyno.2010.07.002","article-title":"Upstaging pathologic stage I ovarian carcinoma based on dense adhesions is not warranted: a clinicopathologic study of 84 patients originally classified as FIGO stage II","volume":"119","author":"Seidman","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib21","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1200\/JCO.1996.14.11.2968","article-title":"Natural history and prognosis of untreated stage I epithelial ovarian carcinoma","volume":"14","author":"Ahmed","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib22","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0140-6736(00)03590-X","article-title":"Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma","volume":"357","author":"Vergote","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib23","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","article-title":"Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome","volume":"14","author":"Tothill","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/AOG.0b013e3181917a0c","article-title":"Influence of intraoperative capsule rupture on outcomes in stage I epithelial ovarian cancer","volume":"113","author":"Bakkum-Gamez","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib25","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/cncr.23390","article-title":"Prognostic factors for high-risk early-stage epithelial ovarian cancer: a gynecologic oncology group study","volume":"112","author":"Chan","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib26","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ygyno.2006.09.021","article-title":"A\u00a0new prognostic model for FIGO stage 1 epithelial ovarian cancer","volume":"104","author":"Obermair","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/IGC.0b013e3181991546","article-title":"Clear cell carcinoma compared to serous carcinoma in early ovarian cancer: same prognosis in a large randomized trial","volume":"19","author":"Timmers","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib28","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1525-1438.2007.00931.x","article-title":"Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer","volume":"17","author":"Harter","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib29","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ygyno.2007.09.014","article-title":"Metastatic lymph node number in epithelial ovarian carcinoma: does it have any clinical significance?","volume":"108","author":"Ayhan","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib30","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1097\/01.pas.0000131530.67979.47","article-title":"Serous carcinoma of the ovary, fallopian tube, or peritoneum presenting as lymphadenopathy","volume":"28","author":"Euscher","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib31","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1555::AID-CNCR10>3.0.CO;2-R","article-title":"Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenectomy have similar survival to Stage I\/II patients and superior survival to other Stage III patients","volume":"83","author":"Onda","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/gyno.1999.5349","article-title":"The validity and significance of substage IIIC by node involvement in epithelial ovarian cancer: impact of nodal metastasis on patient survival","volume":"73","author":"Kanazawa","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib33","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/jnci\/dji102","article-title":"Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial","volume":"97","author":"Panici","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib34","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ygyno.2006.08.047","article-title":"Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only?","volume":"103","author":"Cliby","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib35","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ygyno.2007.05.016","article-title":"Ovarian cancer patients with \u201cnode-positive-only\u201d Stage IIIC disease have a more favorable outcome than Stage IIIA\/B","volume":"107","author":"Ferrandina","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3802\/jgo.2008.19.4.223","article-title":"Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer","volume":"19","author":"Baek","year":"2008","journal-title":"J\u00a0Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib37","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/PGP.0b013e3182988dfd","article-title":"Stage IIIC ovarian\/peritoneal serous carcinoma: a heterogeneous group of patients with different prognoses","volume":"33","author":"Bakkar","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib38","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/00000478-200209000-00002","article-title":"Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion","volume":"26","author":"Prat","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bpobgyn.2015.03.006_bib39","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/PAS.0b013e31825793e1","article-title":"Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma","volume":"36","author":"Djordjevic","year":"2012","journal-title":"Am J Surg Pathol"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169341500053X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169341500053X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T22:22:00Z","timestamp":1537741320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169341500053X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S152169341500053X"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2015.03.006","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian, fallopian tube and peritoneal cancer staging: Rationale and explanation of new FIGO staging 2013","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2015.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}